OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies
Sana Raoof, Richard J. Lee, Kunal Jajoo, et al.
Cancer Epidemiology Biomarkers & Prevention (2022) Vol. 31, Iss. 6, pp. 1139-1145
Open Access | Times Cited: 15

Showing 15 citing articles:

Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
Juliane Liberto, Sheng-Yin Chen, Ie‐Ming Shih, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2885-2885
Open Access | Times Cited: 61

Transforming cancer screening: the potential of multi-cancer early detection (MCED) technologies
Mitsuho Imai, Yoshiaki Nakamura, Takayuki Yoshino
International Journal of Clinical Oncology (2025)
Open Access

Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies
Ruth Etzioni, Roman Gulati, Christos Patriotis, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 116, Iss. 2, pp. 189-193
Open Access | Times Cited: 11

Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling
Jane Lange, Kemal Çağlar Göğebakan, Roman Gulati, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 6, pp. 830-837
Closed Access | Times Cited: 3

Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening
Hormuzd A. Katki, Philip C. Prorok, Philip E. Castle, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 8, pp. 1280-1287
Open Access | Times Cited: 3

Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types
James Y. Dai, E. Georg Luebeck, Ellen T. Chang, et al.
Journal of Medical Screening (2024) Vol. 31, Iss. 4, pp. 211-222
Open Access | Times Cited: 3

Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?
Michael J. Duffy, John Crown
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 61, Iss. 4, pp. 241-253
Closed Access | Times Cited: 7

Pancreatic Cancer Health Disparity: Pharmacologic Anthropology
Nathan R. Wall, Ryan N. Fuller, Ann Morcos, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5070-5070
Open Access | Times Cited: 6

Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening
Ping Hu, Philip C. Prorok, Hormuzd A. Katki
JNCI Journal of the National Cancer Institute (2024)
Open Access | Times Cited: 1

The Need for Randomized Clinical Trials Demonstrating Reduction in All-Cause Mortality With Blood Tests for Cancer Screening
Sanket S. Dhruva, Rebecca Smith‐Bindman, Rita F. Redberg
JAMA Internal Medicine (2023) Vol. 183, Iss. 10, pp. 1051-1051
Closed Access | Times Cited: 4

Considerations in the Implementation of Multicancer Early Detection Tests
Lincoln Nadauld, Dana P. Goldman
Future Oncology (2022) Vol. 18, Iss. 28, pp. 3119-3124
Open Access | Times Cited: 6

Benefits and Harms of Interception and Early Detection of Cancer
Giovanni Parmigiani
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 4, pp. 731-741
Closed Access

Early detection of non-small cell lung cancer using electronic health record data
Xiudi Li, Rui Yuan, Stephen Kuperberg, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Winning the Battle But Losing the War: Single-Cancer Screening Trials
Sana Raoof
Journal of Clinical Oncology (2022) Vol. 41, Iss. 5, pp. 1147-1147
Open Access | Times Cited: 1

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 15 citing articles:

Your Privacy